Trial intelligence / Profile preview

Yuxuebi Tablet for Night Pain in Ankylosing Spondylitis

NCT04934059Phase 4Unknown

Sponsor
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Start
Jul 2021
Primary completion
Jan 2022
Modality
TCM (Traditional Chinese Medicine)
Countries
1
01

Overview

A Phase 4 trial of Yuxuebi in ankylosing spondylitis (AS), sponsored by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.. Status: unknown.

02

Drugs

Yuxuebi
03

Conditions

ankylosing spondylitis (AS)

Beyond the preview

Go deeper on NCT04934059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04934059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call